Obstetrics & Gynecology Track the topics, authors and articles important to you
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Obstetrics & Gynecology 2007;109:1129-1135
© 2007 by The American College of Obstetricians and Gynecologists
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Casey, B. M.
Right arrow Articles by Cunningham, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Casey, B. M.
Right arrow Articles by Cunningham, G. F.
Related Collections
Right arrow Epidemiology/public health
Right arrow Medical complications of pregnancy

ORIGINAL RESEARCH

Perinatal Significance of Isolated Maternal Hypothyroxinemia Identified in the First Half of Pregnancy

Brian M. Casey, MD1, Jodi S. Dashe, MD1, Catherine Y. Spong, MD1, Donald D. McIntire, PhD1, Kenneth J. Leveno, MD1 and Gary F. Cunningham, MD1

From the 1Department of Obstetrics and Gynecology, the University of Texas Southwestern Medical Center, Dallas, Texas.

OBJECTIVE: To establish pregnancy-specific free thyroxine thresholds and to assess perinatal effects associated with isolated maternal hypothyroxinemia identified in the first half of pregnancy.

METHODS: Stored serum samples from 17,298 women who previously underwent thyroid-stimulating hormone (TSH) screening in the first half of pregnancy were analyzed for free thyroxine (T4) concentrations and thyroid peroxidase antibodies. Women with a free T4 below 0.86 ng/dL but a normal-range TSH were identified to have isolated maternal hypothyroxinemia. Pregnancy outcomes in these women were compared to those with a normal TSH and free T4. Thyroid peroxidase antibody status and the relationship between TSH and free T4 were analyzed for these women and women with subclinical hypothyroidism.

RESULTS: Isolated maternal hypothyroxinemia was identified in 233 women (1.3%). There were not any excessive adverse pregnancy outcomes in these women. Positive thyroid peroxidase antibody assays (greater than 50 international units/mL) were similar in normal women (4%) and those with isolated hypothyroxinemia (5%) but were greater in women with subclinical hypothyroidism (31%, P<.001). There was a negative correlation between TSH and free T4 in normal women (rs=–0.19, P<.001) and those with subclinical hypothyroidism (rs=–0.11, P=.007). The correlation in women with isolated hypothyroxinemia was not significant.

CONCLUSION: Isolated maternal hypothyroxinemia has no adverse effects on perinatal outcome. Moreover, unlike subclinical hypothyroidism, there was a low prevalence of thyroid peroxidase antibodies and no correlation between TSH and free T4 levels in women with hypothyroxinemia, leading us to question its biological significance.

LEVEL OF EVIDENCE: II




This article has been cited by other articles:


Home page
Obstet GynecolHome page
J. Cleary-Goldman, F. D. Malone, G. Lambert-Messerlian, L. Sullivan, J. Canick, T. F. Porter, D. Luthy, S. Gross, D. W. Bianchi, M. E. D'Alton, et al.
Maternal Thyroid Hypofunction and Pregnancy Outcome
Obstet. Gynecol., July 1, 2008; 112(1): 85 - 92.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American College of Obstetricians and Gynecologists.